Suchergebnisse - "Lee, Wang Jun"

PubPharm (26)

11

K-ras T Pharmaceutical Composition For Preventing Or Treating Melanoma Comprising K-ras Specific Activated T Cell And Manufacturing Method Thereof

enthalten in: Europäisches Patentamt | 2023

von LEE WANG JUN | MOON HYOUN JONG | LIM SUN KI

12

INFECTIOUS DISEASE TREATMENT SYSTEM INCLUDING MOBILITY CLINIC VEHICLE

enthalten in: Europäisches Patentamt | 2023

von LEE WANG JUN

13

ANTIGEN COMPOSITION FOR INDUCING KRAS-SPECIFIC ACTIVATED T CELLS

enthalten in: Europäisches Patentamt | 2023

von LEE WANG JUN | MOON HYOUN JONG | LIM SUN KI | +1

14

KRAS T Antigen Composition For Inducing KRAS Specific Activated T Cell

enthalten in: Europäisches Patentamt | 2023

von LEE WANG JUN | MOON HYOUN JONG | LIM SUN KI | +1

15

Neurological and Psychiatric Manifestations of Post-COVID-19 Conditions

enthalten in: Journal of Korean medical science | 2023

von Jung, Y. | Ha, E. | Park, J. | +3

16

Measurement and Control of Surgical Smoke to Enhance Surgical Team Safety

enthalten in: Journal of Korean medical science | 2022

von Moon, H. | Lee, W.

17

Persistent Symptoms After Acute COVID-19 Infection in Omicron Era

enthalten in: Journal of Korean medical science | 2022

von Jung, Y. | Ha, E. | Choe, K. | +3

18

Infectious disease treatment with mobility clinic vehicle

enthalten in: Europäisches Patentamt | 2022

von LEE WANG JUN

19

A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms

enthalten in: The Korean journal of internal medicine | 2020

von Kim, N. | Choe, P. | Park, S. | +6

20

The Author's Response : Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR

enthalten in: Journal of Korean medical science | 2020

von Lim, J. | Jeon, S. | Shin, H. | +7

CommentOn: J Korean Med Sci. 2020 Feb 17;35(6):e79. - PMID 32056407